Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.94 +0.07 (+1.81%)
At close: Oct 22, 2026 · 4:00 PM EDT

Unicycive Therapeutics (UNCY) Preferred Stock Liabilities (2023 - 2024)

Updated

Unicycive Therapeutics (UNCY) reported Preferred Stock Liabilities of $46.19 million for Q2 2024, up 76.3% from $26.2 million a year earlier and unchanged from the prior quarter.

Analysis

Unicycive Therapeutics (UNCY) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

Dating back to Q1 2023, Unicycive Therapeutics' Preferred Stock Liabilities record includes 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Unicycive Therapeutics 106.32 Mn -93.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 46.19 Mn
Mar 31, 2024 46.19 Mn
Jun 30, 2023 26.20 Mn
Mar 31, 2023 25.60 Mn
API Access

Unicycive Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=UNCY&period=max&api_key=YOUR_API_KEY